Kristin Yarema is President and CEO of Poseida Therapeutics Inc.
Person profile
Roles
Poseida Therapeutics
President and CEO
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Poseida Therapeutics, Inc.
4 Jan 24
4
Poseida Therapeutics, Inc.
12 Apr 23
3
Poseida Therapeutics, Inc.
12 Apr 23
4
Atara Biotherapeutics, Inc.
3 Mar 22
4
Atara Biotherapeutics, Inc.
15 Jun 21
4
Atara Biotherapeutics, Inc.
20 May 21
4
Atara Biotherapeutics, Inc.
3 Mar 21
4
Atara Biotherapeutics, Inc.
3 Mar 20
4
Atara Biotherapeutics, Inc.
19 Feb 20
3
Atara Biotherapeutics, Inc.
19 Feb 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | PSTX Poseida Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 250,000 | 0.00 | 606,836 |
2 Jan 24 | PSTX Poseida Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.38 | 345,200 | 1.17 mm | 345,200 |
11 Apr 23 | PSTX Poseida Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 356,836 | 0.00 | 356,836 |
11 Apr 23 | PSTX Poseida Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.62 | 498,325 | 1.31 mm | 498,325 |